PT1056454E - Utilizacao de compostos macrolido para o tratamento do glaucoma - Google Patents

Utilizacao de compostos macrolido para o tratamento do glaucoma

Info

Publication number
PT1056454E
PT1056454E PT99905206T PT99905206T PT1056454E PT 1056454 E PT1056454 E PT 1056454E PT 99905206 T PT99905206 T PT 99905206T PT 99905206 T PT99905206 T PT 99905206T PT 1056454 E PT1056454 E PT 1056454E
Authority
PT
Portugal
Prior art keywords
treatment
glaucoma
utilization
compounds
macrolid
Prior art date
Application number
PT99905206T
Other languages
English (en)
Inventor
Shozo Sakuma
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP1955A external-priority patent/AUPP195598A0/en
Priority claimed from AUPP2992A external-priority patent/AUPP299298A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT1056454E publication Critical patent/PT1056454E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT99905206T 1998-02-23 1999-02-17 Utilizacao de compostos macrolido para o tratamento do glaucoma PT1056454E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP1955A AUPP195598A0 (en) 1998-02-23 1998-02-23 New use
AUPP2992A AUPP299298A0 (en) 1998-04-16 1998-04-16 New use

Publications (1)

Publication Number Publication Date
PT1056454E true PT1056454E (pt) 2003-08-29

Family

ID=25645716

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99905206T PT1056454E (pt) 1998-02-23 1999-02-17 Utilizacao de compostos macrolido para o tratamento do glaucoma

Country Status (9)

Country Link
US (1) US6384073B1 (pt)
EP (1) EP1056454B1 (pt)
JP (1) JP2002503692A (pt)
AT (1) ATE238792T1 (pt)
DE (1) DE69907418T2 (pt)
DK (1) DK1056454T3 (pt)
ES (1) ES2192832T3 (pt)
PT (1) PT1056454E (pt)
WO (1) WO1999042104A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US7265150B1 (en) * 1998-08-14 2007-09-04 Gpi Nil Holdings Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
AR034103A1 (es) * 1999-11-12 2004-02-04 Alcon Inc Composicion farmaceutica que comprende ligandos de neurofilina para el tratamiento de condiciones oculares
GB0012383D0 (en) * 2000-05-22 2000-07-12 Novartis Ag Organic compounds
WO2003061519A2 (en) * 2002-01-18 2003-07-31 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
PL1904056T3 (pl) 2005-07-18 2009-09-30 Minu Llc Zastosowanie makrolidu do przywracania czucia rogówkowego
WO2007019427A2 (en) * 2005-08-08 2007-02-15 Massachusetts Eye & Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
CA2664697A1 (en) 2006-09-28 2008-04-10 Follica, Inc. Methods, kits, and compositions for generating new hair follicles and growing hair
CN101573109A (zh) * 2006-12-28 2009-11-04 利默里克生物制药公司 用于治疗的方法和组合物
ES2435197T3 (es) 2007-01-10 2013-12-16 Board Of Regents, The University Of Texas System Administración mejorada de composiciones de fármacos inmunosupresores para la administración por vía pulmonar
BRPI0814876A2 (pt) * 2007-07-31 2014-09-30 Limerick Biopharma Inc Análogos de pirona fosforilados e métodos
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
US20140147413A1 (en) * 2011-02-28 2014-05-29 Dong Feng Chen Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
US10428331B2 (en) 2014-01-16 2019-10-01 Musc Foundation For Research Development Targeted nanocarriers for the administration of immunosuppressive agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
WO1992019278A1 (en) * 1991-04-26 1992-11-12 Kurume University Use of macrolide compounds for eye diseases
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5912224A (en) * 1996-02-22 1999-06-15 The General Hospital Corporation Methods and compositions for enhancing cellular response to TGF-β ligands
US5994388A (en) * 1997-03-18 1999-11-30 The Children's Medical Center Corporation Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis

Also Published As

Publication number Publication date
DE69907418T2 (de) 2003-11-13
DK1056454T3 (da) 2003-08-18
EP1056454B1 (en) 2003-05-02
ES2192832T3 (es) 2003-10-16
US6384073B1 (en) 2002-05-07
ATE238792T1 (de) 2003-05-15
WO1999042104A1 (en) 1999-08-26
EP1056454A1 (en) 2000-12-06
DE69907418D1 (de) 2003-06-05
JP2002503692A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DK0915898T3 (da) Krystalform I af clarithromycin
PE14199A1 (es) Agonistas de 5-ht1f
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
BR0015392A (pt) Lipoxina a4 e seus análogos para o tratamento de olho ressecado
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
AUPP223198A0 (en) New use
ID25478A (id) Agonis 5-ht1f
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
SE9902673D0 (sv) New composition
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
PE64099A1 (es) Antibiotico derivado de cefalosporinas